News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dendreon Corporation Moving HQ to Selig Building on Waterfront
May 4, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Seattle Times -- Seattle biotech Dendreon, fresh off winning regulatory approval for its cancer therapy, confirmed Monday it's moving its headquarters and other local operations to a brand-new, bigger building.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Patents
AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement
September 12, 2025
·
2 min read
·
Tristan Manalac
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
·
2 min read
·
Tristan Manalac
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
·
2 min read
·
Annalee Armstrong
Business
New York City’s Life Sciences Scene Grows in Stature
September 11, 2025
·
5 min read
·
Angela Gabriel
